AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OnKure Therapeutics, Inc. Director's Dealing 2021

Apr 15, 2021

Director's Dealing

Opens in your device viewer

Issuer: Reneo Pharmaceuticals, Inc. (RPHM)
CIK: 0001637715
Period of Report: 2021-04-08

Reporting Person: GREY MICHAEL G (Director, Executive Chairman)

Security	Shares	Ownership
Common Stock	424600	Indirect

F1: The number of shares was misstated as 424,601 in the Reporting Person's original Form 3.

F2: By The Grey Family Trust dated November 12, 1999